Diabetes Care, Vol 16, Issue 11 1470-1478, Copyright © 1993 by American Diabetes Association

ARTICLES

A prospective study identifying risk factors for discontinuance of insulin pump therapy

JC Floyd, RG Cornell, SJ Jacober, LE Griffith, MM Funnell, LL Wolf and FM Wolf
Department of Internal Medicine, University of Michigan, Ann Arbor.

OBJECTIVE--To identify characteristics of adult patients at baseline associated with duration of subsequent, continuous, subcutaneous infusion of insulin treatment (pump therapy) of type I diabetes. RESEARCH DESIGN AND METHODS--For 6 wk, patients followed a standardized conventional therapy and kept a record of insulin dosages, capillary blood glucose concentrations, and symptomatic hypoglycemia. They were then hospitalized. Additional baseline data were obtained and pump therapy was started. Survival analysis was used to determine the relationship between baseline independent variables or risk factors and duration of pump therapy, which is the dependent variable. RESULTS--Of the 68 participants, 33 (49%) terminated pump therapy after an average of 9.9 mo of treatment. Two models (each P < 0.00005) were developed that exhibited a high degree of consistency. Of the 6 variables, 5 were common to both models (HbA1, autonomic neuropathy, mean amplitude of glycemic excursions, frequency of symptoms of hypoglycemia when blood glucose was < 70 mg/dl, and erythema at injection sites). The sixth variable in model 1 (insulin dosage) was replaced in model 2 by a variable, Adult Self-Efficacy for Diabetes, which was obtained on the 33 more recently enrolled patients; this variable related to patient perceptions of self-care behaviors. CONCLUSIONS--We found that, at baseline, the presence of a high concentration of HbA1 and a low estimation by the patient of their ability to treat the disease portend failure of insulin pump therapy as evidenced by its discontinuation. This effect is accentuated when clinical evidence of autonomic neuropathy is observed. These findings offer guidance in selecting patients with type I diabetes for insulin pump therapy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				S. L. Smith and R. L. West The application of self-efficacy principles to audiologic rehabilitation: a tutorial. Am J Audiol, June 1, 2006; 15(1): 46 - 56. [Abstract] [Full Text] [PDF]

				J. Weissberg-Benchell, J. Antisdel-Lomaglio, and R. Seshadri Insulin Pump Therapy: A meta-analysis Diabetes Care, April 1, 2003; 26(4): 1079 - 1087. [Abstract] [Full Text] [PDF]

				J. A. Sanfield, M. Hegstad, and R. S. Hanna Protocol for Outpatient Screening and Initiation of Continuous Subcutaneous Insulin Infusion Therapy: Impact on Cost and Quality The Diabetes Educator, July 1, 2002; 28(4): 599 - 607. [Abstract] [PDF]

				F. R. Cogen, R. Streisand, and S. Sarin Selecting Children and Adolescents for Insulin Pump Therapy: Medical and Behavioral Considerations Diabetes Spectr, April 1, 2002; 15(2): 72 - 75. [Full Text] [PDF]

				C. M. Clark Jr., M. H. Chin, S. N. Davis, E. Fisher, R. G. Hiss, D. G. Marrero, E. A. Walker, and J. Wylie-Rosett Incorporating the Results of Diabetes Research Into Clinical Practice: Celebrating 25 years of Diabetes Research and Training Center translation research Diabetes Care, December 1, 2001; 24(12): 2134 - 2142. [Full Text] [PDF]